Skip to content
healthcare.dev

RELENZA

NDC 50090-8016, zanamivir, powder, from A-S Medication Solutions.

Product NDC
50090-8016
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021036
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8016 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZANAMIVIR5 mg/1

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
50090-8016-0500908016005 PACKAGE in 1 CARTON (50090-8016-0) / 4 POWDER in 1 PACKAGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b4e68930-4e6d-4d27-b1f0-abf60d12e28d

Use it

Look up 50090-8016 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8016 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-8016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.